University of British Columbia
W04.4- Impact of Elexacaftor-Tezacaftor-Ivacaftor on the predicted 3-year risk of death or lung transplantation for individuals with advanced CF lung disease.
Thursday, September 26, 202410:15 AM – 12:15 PM ET
W22--Lungs & Beyond
Friday, September 27, 202410:15 AM – 12:15 PM ET